Belgium: MDxHealth raises US$45m from IPO of ADS to fund growth

MDxHealth, a commercial-stage precision diagnostics company, has priced its IPO of 3.75 million ADS (each representing 10 ordinary shares) at US$12 per ADS, raising total gross proceeds of US$45m. There is a 30-day option to purchase additional ordinary shares of up to 15% of the total. Proceeds will go towards increase the company’s financial flexibility…

You must be a HMI Subscriber to view this content.

Subscribe Now »